Results 281 to 290 of about 5,312,572 (347)

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

open access: yesMolecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek   +2 more
wiley   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

open access: yesMolecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

Early Prediction of Paroxysmal Atrial Fibrillation in Patients With Acute Stroke Using the BANQMR Score. [PDF]

open access: yesJ Clin Neurol
Suzuki S   +9 more
europepmc   +1 more source

Continuous indices to assess the phenotypic spectrum of kidney transplant rejection. [PDF]

open access: yesNat Commun
Vaulet T   +30 more
europepmc   +1 more source

LEAST as a novel prediction model of hepatocellular carcinoma development in patients with chronic hepatitis B: a multi-center study. [PDF]

open access: yesBMC Med
Song J   +12 more
europepmc   +1 more source

Intravascular ultrasound-guided percutaneous coronary intervention in acute coronary syndrome stratified by the TVF-ACS risk score: the IVUS-ACS trial. [PDF]

open access: yesEur Heart J Open
Kan J   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy